Near patient cholesterol testing using the Cholestech LDX

Medical Services Advisory Committee
Record ID 32002000071
Authors' objectives:

This report aims to assess the effectiveness of near patient cholesterol testing using the Cholestech LDX.

Authors' recommendations: On the strength of evidence pertaining to near patient cholesterol testing using Cholestech LDX: - The unrestricted use of near patient cholesterol testing using the Cholestech LDX is not recommended; - The restricted use of near patient cholesterol testing, as an alternative to laboratory testing of lipids, should be considered in settings or circumstances where there is adequate training, accreditation and quality assurance. Interim funding in these circumstances should be considered with monitoring and review of testing to assess diagnostic performance and to ensure there is not an increase in testing or broadening of indications beyond that currently undertaken; and - It is strongly recommended that further information be collected on the diagnostic performance of the NPT devices in the community setting and the impact of near patient testing on patient outcomes including changes in lipid management, compliance with lipid lowering therapies and amount of doctor visits.
Authors' methods: Review
Project Status: Completed
Year Published: 2001
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Point-of-Care Systems
  • Cholesterol
  • Hypercholesterolemia
Organisation Name: Medical Services Advisory Committee
Contact Address: MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
Contact Email:
Copyright: Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.